BONESUPPORT Investor Relations Material
Latest events
Q1 2025
BONESUPPORT
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from BONESUPPORT HOLDING
Access all reports
Segment Data
Access more data
Revenue by
Products
CERAMENT BVF
CERAMENT G and CERAMENT V
Other
Expenses by
Financials
BONESUPPORT HOLDING, an orthobiologics company, develops and commercializes injectable bioceramic bone graft substitutes for the treatment of bone voids in Europe, North America, and internationally. The company's product, CERAMENT is a medical device that helps stimulate and accelerate the patient's own bone healing process. It is also involved in designing, developing, manufacturing, selling, marketing, and distributing of therapeutic products; and provision of research activities for new applications for drugs
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
BONEX
Country
🇸🇪 Sweden